Strategy is only valuable when the organization can execute it

In clinical-stage biotech, the challenge is rarely ambition or scientific direction. Progress slows when priorities are unclear, decisions are delayed, and execution breaks down across functions.

The RightHand Strategy partners with biotech leadership teams to build the operational backbone for R&D execution—ensuring strategy translates into aligned, actionable plans, effective decisions, and consistent delivery.

Where Organizations get stuck

As organizations scale, complexity increases. Planning becomes more demanding, cross-functional coordination becomes critical, and decisions carry greater impact.

Without the right structure, common challenges emerge:

• Priorities are not consistently understood
• Decision-making is slow or unclear
• Planning processes do not translate into execution
• Ownership and accountability are diffused

How I help

I design and implement the systems that connect strategy to execution, including:

• Strategic planning and multi-year R&D roadmapping
• Governance and decision-making frameworks
• Cross-functional alignment across Clinical, Regulatory, and Medical
• Resource planning tied to portfolio priorities
• Execution tracking through metrics, dashboards, and operating cadence

The focus is not just on defining strategy—but ensuring it is actionable, aligned, and executed consistently across the organization.